TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Taking Action Together: Development, Implementation and Evaluation of Community-Based Programs That Aims to Reduce Risk of Type 2 Diabetes in High BMI African American Children.
Brief Summary: The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control group.


Options:
A: Arm Label: Parenting Insight; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Parenting Insights | Arm Label: Child Safety Insights; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Child Safety Insights | Intervention Type: BEHAVIORAL; Name: Child Safety Insights; Assigned to Arm(s): Child Safety Insights | Intervention Type: BEHAVIORAL; Name: Parenting Insights; Assigned to Arm(s): Parenting Insight
B: Arm Label: AA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Arm Label: HA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Intervention Type: BEHAVIORAL; Name: Increase vegetable intake in pre-school children; Assigned to Arm(s): AA - Increase vegetable intake, HA - Increase vegetable intake
C: Arm Label: Level of intervention intensity; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity, Behavioral: Low Intensity | Intervention Type: BEHAVIORAL; Name: High Intensity; Assigned to Arm(s): Level of intervention intensity | Intervention Type: BEHAVIORAL; Name: Low Intensity; Assigned to Arm(s): Level of intervention intensity
D: Arm Label: parent intervention plus gym lessons; Type: EXPERIMENTAL; Interventions: Behavioral: parent-focused intervention, Behavioral: twice weekly gym lessons | Arm Label: gym lessons only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: twice weekly gym lessons | Intervention Type: BEHAVIORAL; Name: parent-focused intervention; Assigned to Arm(s): parent intervention plus gym lessons | Intervention Type: BEHAVIORAL; Name: twice weekly gym lessons; Assigned to Arm(s): gym lessons only, parent intervention plus gym lessons

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Taking Action Together: Development, Implementation and Evaluation of Community-Based Programs That Aims to Reduce Risk of Type 2 Diabetes in High BMI African American Children.
Brief Summary: The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control group.


Options:
A: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Wait-listed control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): intervention
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
C: Arm Label: Level of intervention intensity; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity, Behavioral: Low Intensity | Intervention Type: BEHAVIORAL; Name: High Intensity; Assigned to Arm(s): Level of intervention intensity | Intervention Type: BEHAVIORAL; Name: Low Intensity; Assigned to Arm(s): Level of intervention intensity
D: Arm Label: parent intervention plus gym lessons; Type: EXPERIMENTAL; Interventions: Behavioral: parent-focused intervention, Behavioral: twice weekly gym lessons | Arm Label: gym lessons only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: twice weekly gym lessons | Intervention Type: BEHAVIORAL; Name: parent-focused intervention; Assigned to Arm(s): parent intervention plus gym lessons | Intervention Type: BEHAVIORAL; Name: twice weekly gym lessons; Assigned to Arm(s): gym lessons only, parent intervention plus gym lessons

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Taking Action Together: Development, Implementation and Evaluation of Community-Based Programs That Aims to Reduce Risk of Type 2 Diabetes in High BMI African American Children.
Brief Summary: The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control group.


Options:
A: Arm Label: AA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Arm Label: HA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Intervention Type: BEHAVIORAL; Name: Increase vegetable intake in pre-school children; Assigned to Arm(s): AA - Increase vegetable intake, HA - Increase vegetable intake
B: Arm Label: Lunch in the Bag Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lunch is in the Bag behavioral intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lunch is in the Bag behavioral intervention; Assigned to Arm(s): Lunch in the Bag Intervention
C: Arm Label: Level of intervention intensity; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity, Behavioral: Low Intensity | Intervention Type: BEHAVIORAL; Name: High Intensity; Assigned to Arm(s): Level of intervention intensity | Intervention Type: BEHAVIORAL; Name: Low Intensity; Assigned to Arm(s): Level of intervention intensity
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 3

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Taking Action Together: Development, Implementation and Evaluation of Community-Based Programs That Aims to Reduce Risk of Type 2 Diabetes in High BMI African American Children.
Brief Summary: The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control group.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Primary (Environmental) Weight Gain Prevention, Behavioral: Secondary (Behavioral) Weight Gain Prevention | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Primary (Environmental) Weight Gain Prevention; Assigned to Arm(s): Arm 1, Arm 2 | Intervention Type: BEHAVIORAL; Name: Secondary (Behavioral) Weight Gain Prevention; Assigned to Arm(s): Arm 2 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Arm 3
C: Arm Label: Bright Futures; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Maternal focused intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Maternal focused intervention | Arm Label: Ounce of Prevention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ounce of Prevention | Intervention Type: BEHAVIORAL; Name: Maternal focused intervention; Assigned to Arm(s): Maternal focused intervention | Intervention Type: BEHAVIORAL; Name: Ounce of Prevention; Assigned to Arm(s): Ounce of Prevention
D: Arm Label: Level of intervention intensity; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity, Behavioral: Low Intensity | Intervention Type: BEHAVIORAL; Name: High Intensity; Assigned to Arm(s): Level of intervention intensity | Intervention Type: BEHAVIORAL; Name: Low Intensity; Assigned to Arm(s): Level of intervention intensity

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Taking Action Together: Development, Implementation and Evaluation of Community-Based Programs That Aims to Reduce Risk of Type 2 Diabetes in High BMI African American Children.
Brief Summary: The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control group.


Options:
A: Arm Label: motivational counseling; Type: EXPERIMENTAL; Interventions: Behavioral: motivational counseling | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: motivational counseling; Assigned to Arm(s): motivational counseling
B: Arm Label: Level of intervention intensity; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity, Behavioral: Low Intensity | Intervention Type: BEHAVIORAL; Name: High Intensity; Assigned to Arm(s): Level of intervention intensity | Intervention Type: BEHAVIORAL; Name: Low Intensity; Assigned to Arm(s): Level of intervention intensity
C: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
D: Arm Label: NOURISH-T; Type: EXPERIMENTAL; Interventions: Behavioral: NOURISH-T | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: NOURISH-T; Assigned to Arm(s): NOURISH-T | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reduction of Person-job Mismatch to Increase Work Capacity, by Education of, and Dialogue Between Involved Parties - Evaluation of an Intervention Program
Brief Summary: The study aims to evaluate the effect on return to work of a workplace intervention with patients being treated for burnout. The intervention intends to reduce job-person mismatch through patient-supervisor communication.The hypothesis is that the intervention group will show a more favourable outcome than a control group with respect to return to work.


Options:
A: Arm Label: Tailored Physical Activity; Type: EXPERIMENTAL; Interventions: Other: Tailored Physical Activity | Arm Label: Reference group; Type: OTHER; Interventions: Behavioral: Health Counselling | Intervention Type: OTHER; Name: Tailored Physical Activity; Assigned to Arm(s): Tailored Physical Activity | Intervention Type: BEHAVIORAL; Name: Health Counselling; Assigned to Arm(s): Reference group
B: Arm Label: PLURIHOC; Type: ACTIVE_COMPARATOR; Interventions: Other: functionnal reeducation | Arm Label: KIPLURI; Type: ACTIVE_COMPARATOR; Interventions: Other: functionnal reeducation | Arm Label: KIMONO; Type: ACTIVE_COMPARATOR; Interventions: Other: functionnal reeducation | Intervention Type: OTHER; Name: functionnal reeducation; Assigned to Arm(s): KIMONO, KIPLURI, PLURIHOC
C: Arm Label: Workplace dialogue; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Workplace dialogue | Arm Label: Care as usual; Type: SHAM_COMPARATOR; Interventions: Other: Care as usual | Intervention Type: BEHAVIORAL; Name: Workplace dialogue; Assigned to Arm(s): Workplace dialogue | Intervention Type: OTHER; Name: Care as usual; Assigned to Arm(s): Care as usual
D: Arm Label: Regular treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Psychoeducation; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducation | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Conservative Treatment for Hip Osteoarthritis: Effect of Manual Treatment and Hip School on Pain, Disability and Quality of Life - a Single-blinded Randomized Controlled Trial
Brief Summary: The purpose of the study is to evaluate the effect of manual treatment and a patient education programme for patients without indication for hip surgery.


Options:
A: Arm Label: Treatment arm 1; Type: ACTIVE_COMPARATOR; Interventions: Other: magnetotherapy | Arm Label: Treatment arm 2; Type: ACTIVE_COMPARATOR; Interventions: Device: laser auriculotherapy | Arm Label: Treatment arm 3; Type: EXPERIMENTAL; Interventions: Other: magnetotherapy, Device: laser auriculotherapy | Arm Label: Placebo arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: OTHER; Name: magnetotherapy; Assigned to Arm(s): Treatment arm 1, Treatment arm 3 | Intervention Type: DEVICE; Name: laser auriculotherapy; Assigned to Arm(s): Treatment arm 2, Treatment arm 3 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo arm
B: Arm Label: APOS; Type: EXPERIMENTAL; Interventions: Device: APOS shoe | Arm Label: Sham APOS; Type: SHAM_COMPARATOR; Interventions: Device: Sham-APOS shoe | Intervention Type: DEVICE; Name: APOS shoe; Assigned to Arm(s): APOS | Intervention Type: DEVICE; Name: Sham-APOS shoe; Assigned to Arm(s): Sham APOS
C: Arm Label: Real mobilization-with-movement (MWM); Type: EXPERIMENTAL; Interventions: Other: Real mobilization-with-movement (MWM) | Arm Label: Sham mobilization-with-movement (MWM); Type: SHAM_COMPARATOR; Interventions: Other: Sham mobilization-with-movement (MWM) | Intervention Type: OTHER; Name: Real mobilization-with-movement (MWM); Assigned to Arm(s): Real mobilization-with-movement (MWM) | Intervention Type: OTHER; Name: Sham mobilization-with-movement (MWM); Assigned to Arm(s): Sham mobilization-with-movement (MWM)
D: Arm Label: Hip school; Type: ACTIVE_COMPARATOR; Interventions: Other: Hip School | Arm Label: Hip School and Manual Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Hip School and Manual Treatment | Arm Label: Minimal control intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Minimal control intervention | Intervention Type: OTHER; Name: Hip School; Assigned to Arm(s): Hip school | Intervention Type: OTHER; Name: Hip School and Manual Treatment; Assigned to Arm(s): Hip School and Manual Treatment | Intervention Type: OTHER; Name: Minimal control intervention; Assigned to Arm(s): Minimal control intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This was a study to evaluate the efficacy and safety of HS219, chitosan-loaded chewing gum, when given three times a day for 3 weeks to the hemodialysis (HD) patients with hyperphosphatemia whose serum inorganic phosphorus was not well controlled with calcium carbonate or sevelamer hydrogen chloride.


Options:
A: Arm Label: HS219; Type: EXPERIMENTAL; Interventions: Dietary Supplement: HS219 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: HS219; Assigned to Arm(s): HS219 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Renal Function Group #1; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #2; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #3; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #4; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #5; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #6; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #7; Type: N/A; Interventions: N/A
C: Arm Label: Renvela; Type: EXPERIMENTAL; Interventions: Drug: Renvela | Arm Label: Etalpha; Type: EXPERIMENTAL; Interventions: Drug: Etalpha | Intervention Type: DRUG; Name: Renvela; Assigned to Arm(s): Renvela | Intervention Type: DRUG; Name: Etalpha; Assigned to Arm(s): Etalpha
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: calcium acetate, Drug: atorvastatin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: sevelamer, Drug: atorvastatin | Intervention Type: DRUG; Name: calcium acetate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: sevelamer; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: atorvastatin; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This was a study to evaluate the efficacy and safety of HS219, chitosan-loaded chewing gum, when given three times a day for 3 weeks to the hemodialysis (HD) patients with hyperphosphatemia whose serum inorganic phosphorus was not well controlled with calcium carbonate or sevelamer hydrogen chloride.


Options:
A: Arm Label: HS219; Type: EXPERIMENTAL; Interventions: Dietary Supplement: HS219 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: HS219; Assigned to Arm(s): HS219 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 900 mg Phosphate Diet-LC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lanthanum Carbonate, Other: 900 mg Phosphate Diet | Arm Label: Ad Libitum Diet-LC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lanthanum Carbonate, Other: Ad Libitum Diet | Arm Label: 900 mg Phosphate Diet-LC Placebo; Type: ACTIVE_COMPARATOR; Interventions: Other: 900 mg Phosphate Diet, Drug: LC Placebo | Arm Label: Ad Libitum Diet-LC Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: LC Placebo, Other: Ad Libitum Diet | Intervention Type: DRUG; Name: Lanthanum Carbonate; Assigned to Arm(s): 900 mg Phosphate Diet-LC, Ad Libitum Diet-LC | Intervention Type: OTHER; Name: 900 mg Phosphate Diet; Assigned to Arm(s): 900 mg Phosphate Diet-LC, 900 mg Phosphate Diet-LC Placebo | Intervention Type: DRUG; Name: LC Placebo; Assigned to Arm(s): 900 mg Phosphate Diet-LC Placebo, Ad Libitum Diet-LC Placebo | Intervention Type: OTHER; Name: Ad Libitum Diet; Assigned to Arm(s): Ad Libitum Diet-LC, Ad Libitum Diet-LC Placebo
C: Arm Label: Subjects with normal kidney function; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: High calcium diet 2000 mg/day, Dietary Supplement: Low calcium diet, 800 mg/day | Arm Label: CKD late Stage 3 and Stage 4; Type: EXPERIMENTAL; Interventions: Dietary Supplement: High calcium diet 2000 mg/day, Dietary Supplement: Low calcium diet, 800 mg/day | Intervention Type: DIETARY_SUPPLEMENT; Name: High calcium diet 2000 mg/day; Assigned to Arm(s): CKD late Stage 3 and Stage 4, Subjects with normal kidney function | Intervention Type: DIETARY_SUPPLEMENT; Name: Low calcium diet, 800 mg/day; Assigned to Arm(s): CKD late Stage 3 and Stage 4, Subjects with normal kidney function
D: Arm Label: 1 grain (soy) protein diet:; Type: ACTIVE_COMPARATOR; Interventions: Other: grain (soy) protein diet | Arm Label: 2 casein (meat) protein diet; Type: ACTIVE_COMPARATOR; Interventions: Other: casein (meat) protein diet | Intervention Type: OTHER; Name: grain (soy) protein diet; Assigned to Arm(s): 1 grain (soy) protein diet: | Intervention Type: OTHER; Name: casein (meat) protein diet; Assigned to Arm(s): 2 casein (meat) protein diet

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3 Randomized, Double-blind Study Of The Efficacy And Safety Of 2 Doses Of Cp-690,550 Compared To Methotrexate In Methotrexate Navie Patients With Rheumatoid Arthritis
Brief Summary: This study is designed to compare the effectiveness of the experimental drug, CP-690,550, to methotrexate in preventing joint damage and improving symptoms of rheumatoid arthritis. This study will also compare the safety of CP-690,550 with methotrexate.


Options:
A: Arm Label: 5 mg BID CP-690,550; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: 10 mg BID CP-690,550; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: methotrexate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Disease-modifying antirheumatic drug | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): 5 mg BID CP-690,550 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): 10 mg BID CP-690,550 | Intervention Type: DRUG; Name: Disease-modifying antirheumatic drug; Assigned to Arm(s): methotrexate
B: Arm Label: Certolizumab pegol 400 mg and placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Certolizumab pegol, Other: Placebo | Arm Label: Certolizumab pegol 200 mg and placebo; Type: EXPERIMENTAL; Interventions: Drug: Certolizumab pegol, Other: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Certolizumab pegol; Assigned to Arm(s): Certolizumab pegol 400 mg and placebo | Intervention Type: DRUG; Name: Certolizumab pegol; Assigned to Arm(s): Certolizumab pegol 200 mg and placebo | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Certolizumab pegol 200 mg and placebo, Certolizumab pegol 400 mg and placebo, Placebo
C: Arm Label: TNF-blocking drug; Type: EXPERIMENTAL; Interventions: Drug: Etanercept, Drug: Adalimumab, Drug: Certolizumab Pegol, Drug: Infliximab, Drug: Golimumab | Arm Label: Abatacept; Type: EXPERIMENTAL; Interventions: Drug: Abatacept | Arm Label: Rituximab; Type: ACTIVE_COMPARATOR; Interventions: Biological: Rituximab | Intervention Type: DRUG; Name: Etanercept; Assigned to Arm(s): TNF-blocking drug | Intervention Type: DRUG; Name: Abatacept; Assigned to Arm(s): Abatacept | Intervention Type: BIOLOGICAL; Name: Rituximab; Assigned to Arm(s): Rituximab | Intervention Type: DRUG; Name: Adalimumab; Assigned to Arm(s): TNF-blocking drug | Intervention Type: DRUG; Name: Certolizumab Pegol; Assigned to Arm(s): TNF-blocking drug | Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): TNF-blocking drug | Intervention Type: DRUG; Name: Golimumab; Assigned to Arm(s): TNF-blocking drug
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: etanercept | Intervention Type: DRUG; Name: etanercept; Assigned to Arm(s): 1

Answer: A